Peptide–Drug Conjugates with Different Linkers for Cancer Therapy-Reference-Cited by-同舟云学术

Peptide–Drug Conjugates with Different Linkers for Cancer Therapy

Published:2020-12-31 Issue:1 Volume:64 Page:216-232
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Alas Mona¹,Saghaeidehkordi Azam¹,Kaur Kamaljit¹^ORCID

Affiliation:

1. Chapman University School of Pharmacy (CUSP), Harry and Diane Rinker Health Science Campus, Chapman University, Irvine, California 92618-1908, United States

Funder

National Cancer Institute

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c01530

Reference73 articles.

1. Prospects for combining targeted and conventional cancer therapy with immunotherapy

2. Novel delivery approaches for cancer therapeutics

3. Antibody–drug conjugates for cancer

4. Peptide Conjugates with Small Molecules Designed to Enhance Efficacy and Safety

5. Antibody–drug conjugates for cancer therapy

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LC-MS/MS method for dual-ligand peptide-drug CBP-1018 and its deconjugated payload MMAE including sample stabilization strategy for its MC-Val-Cit-PABC linker;Talanta;2024-11

2. Advances in tumor stroma-based targeted delivery;International Journal of Pharmaceutics;2024-10

3. Design and synthesis of TH19P01-Camptothecin based hybrid peptides inducing effective anticancer responses on sortilin positive cancer cells;Bioorganic & Medicinal Chemistry;2024-09

4. Structural modification strategies of triazoles in anticancer drug development;European Journal of Medicinal Chemistry;2024-09

5. Varianten biotechnologischer Arzneistoffe in der Dermatologie;Die Dermatologie;2024-08-22